Forecast: Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods in the UK

Between 2024 and 2028, the forecasted healthcare expenditure on pharmaceuticals and medical non-durable goods in the UK is projected to decrease from 11.16% to 10.82% of total current health expenditure. The data indicates a gradual but steady decline in percentage allocation over this period, with a year-on-year decrease averaging around 0.8% annually. As of 2023, the expenditure was already trending downward, setting the stage for this continued reduction.

Looking forward, key trends to monitor include the impact of generic drug adoption, shifts in healthcare policy, and advancements in biotech, which could further alter expenditure patterns. Additionally, economic shifts and healthcare priorities post-pandemic will be crucial in shaping future spending dynamics.